Eagle Pharmaceuticals
Presence
Eagle Pharmaceuticals is one of the...
Eagle Pharmaceuticals is a company listed under the stock ticker EGRX (US).
Acquisition, funding and merger involving Eagle Pharmaceuticals.
- Revelation Pharma has announced the acquisition of Eagle Pharmaceuticals (posted on July 24 2023).
Executives
View the org chart displaying its 8 main executives
Most searched biographies at Eagle Pharmaceuticals
- Michael Graves, Interim Executive Chairman of the Board
- Robert Glenning, Director
- Richard Edlin, Director
Popular executive movements at Eagle Pharmaceuticals
- Steven Ratoff, who was Non-Executive Director, is promoted to Non-Executive Director and Interim Chief Financial Officer (posted on March 11 2024).
- Brian Cahill, Chief Financial Officer, has left the company (posted on March 11 2024).
- Scott Tarriff, President, Chief Executive Officer and Director, has left the company (posted on November 29 2023).
Create your alert
to follow the executive moves at Eagle Pharmaceuticals.
Pharmaceuticals
Eagle Pharmaceuticals has 1,860 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- MedMen has filed for bankruptcy protection (posted on April 28 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Eagle Pharmaceuticals
- Eagle Pharmaceuticals’ Japanese Licensing Partner SymBio Announces Completion of Clinical Trial Enrollment for TREAKISYM® Rapid Infusion Liquid Bendamustine Formulation | Eagle Pharmaceuticals Investor Center
- Press Releases | Eagle Pharmaceuticals Investor Center
- Eagle Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Results | Eagle Pharmaceuticals Investor Center
- Eagle Pharmaceuticals to Discuss Fourth Quarter and Full Year 2019 Financial Results on March 2, 2020 | Eagle Pharmaceuticals Investor Center
- Eagle Pharmaceuticals Receives Final FDA Approval for PEMFEXY™ (Pemetrexed for Injection) | Eagle Pharmaceuticals Investor Center
- Eagle Pharmaceuticals to Develop Dantrolene Sodium for Potential Treatment of Alzheimer’s Disease in Collaboration With University of Pennsylvania | Eagle Pharmaceuticals Investor Center
- Eagle Pharmaceuticals Resubmits NDA for RYANODEX for Exertional Heat Stroke | Eagle Pharmaceuticals Investor Center
- Tyme Technologies and Eagle Pharmaceuticals Announce Strategic Collaboration to Advance Innovative Oral SM-88 for the Treatment of Patients with Cancer | Eagle Pharmaceuticals Investor Center
- Eagle Pharmaceuticals and NorthShore University HealthSystem to Study Dantrolene Sodium for the Treatment of Concussion and Other Forms of Traumatic Brain Injury | Eagle Pharmaceuticals Investor Center
- Press Releases | Eagle Pharmaceuticals Investor Center
- View more press releases Close
Social media about Eagle Pharmaceuticals
- Eagle Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- Eagle Pharmaceuticals on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Daniel O'Connor 
Call Eagle Pharmaceuticals at +1 201...
